Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol
Yaseen M. Arabi(World Health Organization), Robert Fowler(Sunnybrook Health Science Centre), Kayvon Modjarrad(Pfizer (United States)), Fahad Al-Hameed, Yusri Taha, Ali H. Hajeer(King Saud bin Abdulaziz University for Health Sciences), Awad Al‐Omari(University of Central Florida), Frederick G. Hayden(University of Virginia Health System), Lisa E. Hensley(National Center for Emerging and Zoonotic Infectious Diseases), Gail Carson, Hanan H. Balkhy(World Health Organization Regional Office for the Eastern Mediterranean), Abderrezak Bouchama(King Saud bin Abdulaziz University for Health Sciences), Khalid S. Al-Khairy, Musharaf Sadat, Laura Merson, Saad Al-Qahtani, John Whitehead(Lancaster University), Sameera Aljohani, Catherine Leport(Université Paris Cité), Nahoko Shindo(World Health Organization), Gernot Rohde(Goethe University Frankfurt), Abdulaziz Al‐Dawood, Thomas Luke(King Saud bin Abdulaziz University for Health Sciences)
Cited by 206
Related Papers
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
|Intensive Care Medicine|2021|5.1k
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021
|Critical Care Medicine|2021|2.8k
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
|New England Journal of Medicine|1986|1.5k